Additionally, in aggressive cancer cells, the small-molecule compound CYD19 has been shown to bind SNAIL, impairing its interaction with CREB-binding protein (CBP)/p300, which consequently impairs CBP/p300-mediated SNAIL acetylation and promoting its degradation through the ubiquitin–proteasome pathway [128]. Here, CREBBP is linked to cancer.